What Is Tirzepatide Sodium Salt?

Tirzepatide Sodium Salt (CAS 2023788‑19‑2) is a long‑acting dual GLP‑1/GIP receptor agonist peptide, widely used as a key raw material and reference standard in metabolic disease research, pharmaceutical process development, and industrial peptide manufacturing. As the upstream core material of the world’s new top‑selling drug, it supports research in glycemic control, weight management, and metabolic syndrome.

Industry Update: Why Tirzepatide Is Dominating the GLP‑1 Market

2026’s annual report confirms tirzepatide as the world’s new top‑selling drug—surpassing semaglutide to claim the throne.

Dual‑target superiority: By simultaneously activating GLP‑1 and GIP receptors, it delivers superior glycemic control and weight management compared to single‑target GLP‑1 agents.

Explosive growth: The anti‑diabetes version (Mounjaro) and weight‑management version (Zepbound) both achieved remarkable year‑over‑year expansion, with the weight management product showing especially strong momentum in the market.

This growth has sparked a race in R&D and production, making high‑purity tirzepatide sodium salt a critical bottleneck for the industry.

Key Product Specifications of Tirzepatide Sodium Salt

Applications: From Lab Research to Industrial Scale

Scientific research applications of tirzepatide sodium salt include in vitro and in vivo studies on GLP‑1/GIP dual-target signaling pathways, metabolic regulation, and diabetes/obesity models; it also serves as a reference standard for HPLC/LC-MS method development and impurity profiling in preclinical development, as well as a tool for comparative analysis that involves benchmarking efficacy against other incretin mimetics, such as semaglutide, in controlled systems.

In pharmaceutical and industrial manufacturing, tirzepatide sodium salt supports API synthesis and process optimization for bulk drug production and scale-up of tirzepatide and long-acting peptide derivatives; it meets consistency and regulatory requirements for bioequivalence and quality control in CDMO and generic R&D, and also acts as a raw material for sustained-release, oral, and other novel dosage forms.

Why Choose Alfa Chemistry for Tirzepatide Sodium Salt?

Quality & Consistency
HPLC & amino acid analysis ensure batch‑to‑batch consistency, critical for reliable R&D and scale‑up. Full documentation (COA, HPLC, characterization data) for regulatory compliance.

Supply & Flexibility
Gram to kilogram scale available, supporting labs, biotechs, and large manufacturers. Stable supply chain to meet surging GLP‑1 industry demand.

Compliance & Safety
Clearly labeled not for personal sale or human use, exclusively for industrial and research applications.

Q&A: Key Insights for Researchers & Procurement Teams

Q1: What’s the difference between tirzepatide sodium salt and the commercial drug Mounjaro/Zepbound?

A: The commercial drug is a sterile, injectable formulation for clinical use. Tirzepatide sodium salt (CAS 2023788‑19‑2) is a research/industrial grade raw material (white powder, ≥98% HPLC purity), not formulated for human administration. It serves as the starting material for API synthesis and preclinical research.

Q2: Can the product be used for in vitro cell studies or in vivo animal models?

A: Yes. It is widely used for in vitro signaling assays (e.g., HEK293 cells) and in vivo animal models (mice/rats) to study glucose‑dependent insulin secretion, weight loss, and metabolic regulation. Always follow institutional biosafety guidelines and ethical approval.

Q3: What purity level is recommended for different applications?

– Lab research & reference standards: ≥98.0% HPLC purity (our standard).
– Process development & scale‑up: ≥98.0% with strict impurity control, supported by COA and lot documentation.
– Analytical method validation: ≥98.0% paired with traceability data for method accuracy.

Q4: Is the product stable during storage and transportation?

A: Store in a cool, dry, light‑protected environment (2–8°C recommended). For long‑term storage, keep sealed and avoid repeated freeze‑thaw cycles. We use vacuum packaging with desiccants to maintain stability during shipping.

Q5: What documentation is provided with each batch?

A: Each batch includes a COA, HPLC chromatogram, and amino acid analysis report to verify purity, identity, and consistency. These documents support regulatory submissions and internal quality audits.

Q6: Are there minimum order quantities (MOQs) for bulk orders?

A: MOQs vary by scale:
– Lab scale (mg): Low MOQ for early‑stage researchers.
– Bulk scale (kg): Customizable to meet production needs, with volume pricing available.

Contact our sales team for the latest quote and lead time.